Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease
RedHill Biopharma Ltd., a specialty biopharmaceutical company, developed RHB-204, a treatment for MAC, and needed…
Certara2023 年 5 月 9 日
Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150
Explore how tumor growth inhibition modeling can support go/no-go decisions in early Phase Ib/II oncology…
Certara2023 年 3 月 24 日
Therapeutic Proteins’ Drug-Drug Interactions: Updates & Challenges
Therapeutic proteins (TP) - and more specifically monoclonal antibodies - are part of the therapeutic…
Certara2022 年 12 月 5 日
Why you should select your drug formulation before starting clinical studies
药物开发者常急于推进发现流程以进入人体试验。Most are…
Certara2022 年 10 月 28 日
3 takeaways from the FDA oligo guidance you need to know
In June 2022, the FDA published their first oligonucleotide clinical pharmacology specific guidance . This…
Certara2022 年 9 月 23 日
